“Sequence VR" Was Exhibited At The V & A Museum In London, As Part Of The London Design Festival. A

JUST THE FAQS: Top Scientists Around the Nation Call for a Unified Microbiome Initiative

Writing in the journal Science this week, a group of top microbiome researchers from around the country, including UC San Diego School of Medicine’s Rob Knight, PhD, and Pieter Dorrestein, PhD, lay out a proposal for what they call a Unified Microbiome Initiative. This latest post in the JUST THE FAQS series takes a look at what that means and why it’s important.

What is the Unified Microbiome Initiative?

The proposed Unified Microbiome Initiative is a national effort to fund, coordinate and accelerate microbiome research — the study of the microbial communities (bacteria, viruses, etc.) that live in, on and around us.

Why do we need this?

According to the authors of this proposal, the microbiome field currently lacks many of the technologies and resources required to take the research from where it is today (i.e., mostly describing what microbes are living where) to the next level — understanding exactly how microbes influence our health and how we might be able to manipulate them to our benefit.

“… such knowledge could transform our understanding of the world and launch innovations in agriculture, energy, health, the environment and more,” the authors write in the proposal.

This ambitious undertaking cannot be accomplished by individual laboratories working in isolation. Developing these tools requires new collaborations between physical, life, and biomedical sciences, engineering and many other disciplines. Advancing this nascent field also depends on attracting, training and supporting multidisciplinary networks of scientists and engineers, all things that could be accomplished through a concerted national effort, Knight, Dorrestein and their co-authors say.

Wait, what is the microbiome again?

Your body contains as many as 10 times more microbial cells than human cells. Even crazier, that adds up to two to 20 million microbial genes, compared to your 20,000 or so human genes. By that measure, you could say you’re actually only about 10 percent human.

Researchers like Knight, Dorrestein and their teams are now mapping the other 90 percent — the collections of microbial genes (“microbiomes”) found in our guts, mouths, skin, and many other locations on and around the body. They’re finding that the makeup of our gut microbiomes is associated with a rapidly growing list of diseases and conditions: food allergies, obesity, inflammatory bowel disease and colon cancer, rheumatoid arthritis, atherosclerosis, asthma, perhaps even anxiety, depression and autism. But researchers don’t yet know why these associations occur, whether they are cause or effect, and whether or not we could use gut microbiome readouts for medical predictions, diagnoses or treatments.

And that’s just the gut microbiome. Imagine what researchers will find when they dive as deeply into the microbiomes of the rest of our bodies, as well as our homes, the ocean and other environments. That’s why Knight, Dorrestein and many other experts are today calling for a collaborative, well-supported United Microbiome Initiative.

To learn more about Knight’s and Dorrestein’s microbiome work, check out: Antibiotic Resistance in Microbiomes, Despite Isolation from Western Civilization

3D Human Skin Maps Aid Study of Relationships Between Molecules, Microbes and Environment

Pictured: Staphylococcus aureus bacteria. Source: NIAID

No bacterium is an island.

Many people think of bacteria as tiny Lone Rangers, paddling their flagellar canoes across the desolate petri dish sea. But in “the wild”, bacteria exist as complex, interwoven, constantly competing social communities.

Every scoop of soil is a battlefield of chemical chatter. Species send out molecular messages-in-a-bottle that ride the waves of diffusion to their mates. Some even thread electrical cables between neighboring cells. Now, new research has identified elaborate shared membranes that let single cells swarm as a superorganism …

Check out my latest article for Wired all about a soil bacterium named Myxococcus xanthus. It’s under everyone’s feet right now, and it has developed one of the most elaborate physical webs ever witnessed in bacteria. That’s it up top, devouring a colony of E. coli using its patented rippling wave attack.

It’s a stealth communication network that lets them hunt like a tiny wolfpack. So cool. Plus I got to use a GIF, so double win.

Once you’re done with that, check out this great TED talk from Bonnie Bassler all about how bacteria communicate.

امين يارب

Penicillin

Penicillin is a widely used antibiotic prescribed to treat staphylococci and streptococci bacterial infections. 

beta-lactam family 

Gram-positive bacteria = thick cell walls containing high levels of peptidoglycan

gram-negative bacteria = thinner cell walls with low levels of peptidoglycan and surrounded by a lipopolysaccharide (LPS) layer that prevents antibiotic entry 

penicillin is most effective against gram-positive bacteria where DD-transpeptidase activity is highest.

Examples of penicillins include:

amoxicillin

ampicillin

bacampicillin

oxacillin

penicillin

Mechanism(s)

Penicillin inhibits the bacterial enzyme transpeptidase, responsible for catalysing the final peptidoglycan crosslinking stage of bacterial cell wall synthesis.

Cells wall is weakened and cells swell as water enters and then burst (lysis)

Becomes permanently covalently bonded to the enzymes’s active site (irreversible)

Alternative theory: penicillin mimics D-Ala D-Ala

Or may act as an umbrella inhibitor

Resistance

production of beta-lactamase - destroys the beta-lactam ring of penicillin and makes it ineffective (eg Staphylococcus aureus - most are now resistant)

In response, synthetic penicillin that is resistant to beta-lactamase is in use including egdicloxacillin, oxacillin, nafcillin, and methicillin. 

Some is resistant to methicillin - methicillin-resistant Staphylococcus aureus (MRSA).  

Demonstrating blanket resistance to all beta-lactam antibiotics -extremely serious health risk.

3D Printing: Make anything you want (by 16x9onglobal)

JUST THE FAQS: Top Scientists Around the Nation Call for a Unified Microbiome Initiative

Writing in the journal Science this week, a group of top microbiome researchers from around the country, including UC San Diego School of Medicine’s Rob Knight, PhD, and Pieter Dorrestein, PhD, lay out a proposal for what they call a Unified Microbiome Initiative. This latest post in the JUST THE FAQS series takes a look at what that means and why it’s important.

What is the Unified Microbiome Initiative?

The proposed Unified Microbiome Initiative is a national effort to fund, coordinate and accelerate microbiome research — the study of the microbial communities (bacteria, viruses, etc.) that live in, on and around us.

Why do we need this?

According to the authors of this proposal, the microbiome field currently lacks many of the technologies and resources required to take the research from where it is today (i.e., mostly describing what microbes are living where) to the next level — understanding exactly how microbes influence our health and how we might be able to manipulate them to our benefit.

“… such knowledge could transform our understanding of the world and launch innovations in agriculture, energy, health, the environment and more,” the authors write in the proposal.

This ambitious undertaking cannot be accomplished by individual laboratories working in isolation. Developing these tools requires new collaborations between physical, life, and biomedical sciences, engineering and many other disciplines. Advancing this nascent field also depends on attracting, training and supporting multidisciplinary networks of scientists and engineers, all things that could be accomplished through a concerted national effort, Knight, Dorrestein and their co-authors say.

Wait, what is the microbiome again?

Your body contains as many as 10 times more microbial cells than human cells. Even crazier, that adds up to two to 20 million microbial genes, compared to your 20,000 or so human genes. By that measure, you could say you’re actually only about 10 percent human.

Researchers like Knight, Dorrestein and their teams are now mapping the other 90 percent — the collections of microbial genes (“microbiomes”) found in our guts, mouths, skin, and many other locations on and around the body. They’re finding that the makeup of our gut microbiomes is associated with a rapidly growing list of diseases and conditions: food allergies, obesity, inflammatory bowel disease and colon cancer, rheumatoid arthritis, atherosclerosis, asthma, perhaps even anxiety, depression and autism. But researchers don’t yet know why these associations occur, whether they are cause or effect, and whether or not we could use gut microbiome readouts for medical predictions, diagnoses or treatments.

And that’s just the gut microbiome. Imagine what researchers will find when they dive as deeply into the microbiomes of the rest of our bodies, as well as our homes, the ocean and other environments. That’s why Knight, Dorrestein and many other experts are today calling for a collaborative, well-supported United Microbiome Initiative.

To learn more about Knight’s and Dorrestein’s microbiome work, check out: Antibiotic Resistance in Microbiomes, Despite Isolation from Western Civilization

3D Human Skin Maps Aid Study of Relationships Between Molecules, Microbes and Environment

Pictured: Staphylococcus aureus bacteria. Source: NIAID

ANTIBIOTICS CHEAT SHEET :)

Also, REMEMBER!!!!

* Sulfonamides compete for albumin with:

Bilirrubin: given in 2°,3°T, high risk or indirect hyperBb and kernicterus in premies

Warfarin: increases toxicity: bleeding

* Beta-lactamase (penicinillase) Suceptible:

Natural Penicillins (G, V, F, K)

Aminopenicillins (Amoxicillin, Ampicillin)

Antipseudomonal Penicillins (Ticarcillin, Piperacillin)

* Beta-lactamase (penicinillase) Resistant:

Oxacillin, Nafcillin, Dicloxacillin

3°G, 4°G Cephalosporins

Carbapenems 

Monobactams

Beta-lactamase inhibitors

* Penicillins enhanced with:

Clavulanic acid & Sulbactam (both are suicide inhibitors, they inhibit beta-lactamase)

Aminoglycosides (against enterococcus and psedomonas)

* Aminoglycosides enhanced with Aztreonam

* Penicillins: renal clearance EXCEPT Oxacillin & Nafcillin (bile)

* Cephalosporines: renal clearance EXCEPT Cefoperazone & Cefrtriaxone (bile)

* Both inhibited by Probenecid during tubular secretion.

* 2°G Cephalosporines: none cross BBB except Cefuroxime

* 3°G Cephalosporines: all cross BBB except Cefoperazone bc is highly highly lipid soluble, so is protein bound in plasma, therefore it doesn’t cross BBB.

* Cephalosporines are "LAME“ bc they  do not cover this organisms 

L  isteria monocytogenes

A  typicals (Mycoplasma, Chlamydia)

M RSA (except Ceftaroline, 5°G)

E  nterococci

* Disulfiram-like effect: Cefotetan & Cefoperazone (mnemonic)

* Cefoperanzone: all the exceptions!!!

All 3°G cephalosporins cross the BBB except Cefoperazone.

All cephalosporins are renal cleared, except Cefoperazone.

Disulfiram-like effect

* Against Pseudomonas:

3°G Cef taz idime (taz taz taz taz)

4°G Cefepime, Cefpirome (not available in the USA)

Antipseudomonal penicillins

Aminoglycosides (synergy with beta-lactams)

Aztreonam (pseudomonal sepsis)

* Covers MRSA: Ceftaroline (rhymes w/ Caroline, Caroline the 5°G Ceph), Vancomycin, Daptomycin, Linezolid, Tigecycline.

* Covers VRSA: Linezolid, Dalfopristin/Quinupristin

* Aminoglycosides: decrease release of ACh in synapse and act as a Neuromuscular blocker, this is why it enhances effects of muscle relaxants.

* DEMECLOCYCLINE: tetracycline that’s not used as an AB, it is used as tx of SIADH to cause Nephrogenic Diabetes Insipidus (inhibits the V2 receptor in collecting ducts)

* Phototoxicity: Q ue S T  ion?

Q uinolones

Sulfonamides

T etracyclines

* p450 inhibitors: Cloramphenicol, Macrolides (except Azithromycin), Sulfonamides

* Macrolides SE: Motilin stimulation, QT prolongation, reversible deafness, eosinophilia, cholestatic hepatitis

* Bactericidal: beta-lactams (penicillins, cephalosporins, monobactams, carbapenems), aminoglycosides, fluorquinolones, metronidazole.

* Baceriostatic: tetracyclins, streptogramins, chloramphenicol, lincosamides, oxazolidonones, macrolides, sulfonamides, DHFR inhibitors.

* Pseudomembranous colitis: Ampicillin, Amoxicillin, Clindamycin, Lincomycin.

* QT prolongation: macrolides, sometimes fluoroquinolones